Advancing Ophthalmic Research with Virscio's Ocular Inflammation Model
Streamline Your Drug Development with Our Comprehensive Ocular Inflammation Solutions
Virscio’s Ocular Inflammation research capabilities are designed to help you overcome regulatory challenges and accelerate your drug development timelines. As a translational research organization with over 20 years of preclinical experience, Virscio integrates advanced methodologies and validated nonhuman primate models to efficiently generate definitive data, enhancing therapeutic development in various medical fields including ophthalmology.
In this overview, we examine Virscio’s approach to ocular inflammation research. Our model involves the intracameral administration of concanavalin A (Con A) to induce a reproducible model of anterior uveitis in nonhuman primates. This model offers short study durations, clinically relevant endpoints, and flexible prevention or intervention study designs, making it an invaluable tool for evaluating the efficacy of test compounds.
Discover how Virscio’s Ocular Inflammation Model can support your research goals, providing a validated, clinically relevant positive control to benchmark the efficacy of test compounds in a time-efficient manner.
Learn More About Our Ocular Inflammation Research Now!
Discover how Virscio’s Ocular Inflammation Model can support your research goals, providing a validated, clinically relevant positive control to benchmark the efficacy of test compounds in a time-efficient manner.
Virscio's commitment to providing world-class research capabilities extends to a variety of preclinical disciplines, including ophthalmic disease models, ensuring you receive comprehensive services from study design to execution and reporting.
In this overview of our Ocular Inflammation Research Model, you will learn about:
- The methodology and advantages of using concanavalin A (Con A) for inducing anterior uveitis.
- The experimental design, including prevention mode studies and post-Con A ophthalmic examinations.
- The clinical relevance of the model for efficacy studies and pharmacodynamic assessments of anti-inflammatory agents.
Connect with Our Experts: Schedule a Consultation Today!
